Page 46 - Ischemic Stroke News Today

The idea of a stroke is frightening because it comes without warning and can change your life forever. Unfortunately, nearly 800,000 people will experience a new or recurrent stroke every

email article Establishing an endovascular therapy (EVT) program at a cardiology cath lab could be done with a minimal learning curve if operators had prior experience with carotid stenting, one tertiary university hospital reported. The program, started in 2012 with the addition of an experienced interventional radiologist as lead operator, had stroke patients achieve good clinical outcomes at 90 days in 47.9% of cases. Importantly, the distribution in modified Rankin Scale (mRS) scores ...

email article Evidence that mobile stroke units (MSUs) could provide better care than standard management by EMS was extended to seven U.S. metropolitan areas in the BEST-MSU study, providing greater impetus to examine their cost-effectiveness in justifying a path to reimbursement. Stroke patients transported in MSUs suffered significantly less disability measured on a utility-weighted modified Rankin Scale (mRS) at 90 days, the weighting reflecting low patient preference for disability r...

Better nurse work environments associated with improved stroke outcomes Stroke remains a leading cause of death worldwide and one of the most common reasons for disability. While a wide variety of factors influence stroke outcomes, data show that avoiding readmissions and long lengths of stay among ischemic stroke patients has benefits for patients and health care systems alike. Although reduced readmission rates among various medical patients have been associated with better nurse work environ...

Clinical trial begins to evaluate SENSE device’s ability to monitor intracranial hemorrhage Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage (ICH) in an acute hospital setting. The SENSE device is a headset equipped with antennae that transmit a low-power tailored radio ...

Bone marrow cell injections may lead to reduction in brain injury after stroke Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke. The study was conducted by Muhammad E. Haque, Ph.D., Sean I. Savitz, M.D., and colleagues from the Institute for Stroke and Cerebrovascular Disease at The University of Texas Health Science Center in Houston. N...

Dementia risk escalates with the number and severity of strokes Having an ischemic stroke increases dementia risk, and that risk escalates with the number and severity of strokes, according to preliminary research to be presented at the American Stroke Associations International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. Ischemic stroke is the most common stro...

A long-term look at Medicare patients shows that Black patients who have an ischemic stroke (blocked blood flow to the brain) die at a higher rate than white patients, even after accounting for preexisting health conditions, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.

Stroke patients were nearly 50% more likely than heart attack patients to develop depression, and female stroke patients had a higher risk of depression than their male counterparts, according to two preliminary studies by the same research group to be presented at the American Stroke Association's International Stroke Conference 2021.

email article Smart home speakers like Amazon Echo can be used to monitor heart rhythms by sonar, researchers report in Communications Biology. The ACTIV-4 Convalescent trial is now underway testing apixaban (Eliquis) for thromboprophylaxis after discharge for moderate-to-severe COVID-19, the NIH announced. Even if heart failure stabilizes without improving on cardiac resynchronization therapy, 5-year prognosis is much better than was thought, "suggesting that the current convention of n...